NasdaqGS:NTRABiotechs
Natera (NTRA) Posted Strong Q2 Results, Is The Stock Fully Priced?
Natera (NTRA) is back in focus after reporting Q2 2026 earnings on August 6, with revenue of US$752.75 million and a narrower net loss, alongside fresh regulatory progress for Signatera in Japan.
See our latest analysis for Natera.
Natera’s share price has eased in the short term, with a 1-month share price return of down 5.65% and a 7-day share price return of down 1.59%. Momentum over longer periods remains strong, reflected in a 90-day share price return of 36.62% and a 1-year total...